|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dipeptidyl peptidase IV(DP IV,CD26)and aminopeptidase N(APN,CD13)as regulators of T cell function and targets of immunotherapy in CNS inflammation显示文摘 | Reinhold D Biton A Pieper S | 2006 | Int Immunopharmacol2006，6，1314： | 1 |
| 2 | Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial 显示文摘 | Biton V Levisohn P Hoyler S Vuong A Hammer AE | 2003 | J Child Neurol2003，18，2： | 1 |
| 3 | In situ activation pattern of Met docking site following renal injury and hypertrophy 显示文摘 | Dekel B Biton S Yerushalmi GM | 2003 | Nephrol Dial Transport2003，18，8： | 1 |
| 4 | Effect of the noval nonsedating histamine H1 recepter antagonist mizolastine on cardiac potassium and sodium currents显示文摘 | Maitre S Godet D | 1998 | Allergy1998，53，： | 1 |
| 5 | A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy 显示文摘 | Sale M E Natarajan S Biton V | 2005 | Epilepsy Behav2005，6，1： | 1 |
| 6 | Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial显示文摘 | Biton V Levisohn P Hoyler S | 2003 | Journals of Child Neurology2003，18，2： | 1 |
| 7 | Dipeptidyl peptidase IV(DP IV,CD26) and aminopeptidase N(APN,CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation显示文摘 | Reinhold D Biton A Pieper S | 2006 | Int Immunopharmacol2006，6，1314： | 1 |
| 8 | Molecular diagnosis of mango malformation disease and phylogeny of Fusarium mangiferae 显示文摘 | Newman Z Freeman S Biton I | 2012 | Phytoparasitica2012，40，： | 1 |
| 9 | A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy显示文摘 | Natarajan S Biton V VuongA et el | 2005 | Epilepsy Behav2005，6，1： | 1 |
| 10 | Dipeptidyl peptidase IV ( DP IV,CD26) and aminopeptidase N ( APN,CD13 ) as regulators of T cell function and targets of immunotherapy in CNS inflammation 显示文摘 | REINHOLD D BITON A PIEPER S | 2006 | Int Immunopharmacol2006，6，1314： | 1 |
| 11 | A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy显示文摘 | Sale ME Natarajan S Biton V | 2005 | Epilepsy&Behavior2005，6，1： | 1 |
| 12 | A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy显示文摘 | Sale ME Natarajan S Biton V Vuong A | 2005 | Epilepsy Behav2005，6，1： | 1 |
| 13 | In Vivo Expansion ofActivated Foxp3+ Regulatory T Cells and Establishment of a Type 2Immune Response upon IL-33 Treatment Protect against Experi-mental Arthritis显示文摘 | Biton J Khaleghparast A than S Thiolat A | 2016 | J Immunol2016，197，5： | 1 |
| 14 | Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trlal显示文摘 | BITON V LEVISOHN P HOYLER S et ol | 2003 | J Child Neurol2003，18，2： | 1 |
| 15 | Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy:results from a post hoc analysis of a randomized, double-blind clinical trial显示文摘 | Biton V Levisohn P Hbyler S | 2003 | J Child Neurol2003，18，： | 1 |
| 16 | Divergent actions by inhibitors of DP IV and APN family enzymes on CD4(+)Teff cell motility and functions显示文摘 | Biton A Ansorge S Bank U | 2011 | Immunobiology2011，216，： | 1 |
| 17 | A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy显示文摘 | Salea ME Natarajanb S Biton V | 2005 | Epilepsy & Behavior2005，6，： | 1 |
| 18 | A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilessy显示文摘 | Sale ME Natajajan S Biton V | 2005 | Epilepsy Behav2005，6，1： | 1 |
| 19 | Addressing the prove nance challenge using zoom显示文摘 | Cohen-Boulakia S Biton O Cohen S | 2008 | Concurrency and Computation Practice and Experience2008，20，： | 1 |
| 20 | Lacosamide: efficacy and safety as oral adjunctive treatment for partial-onset seizures显示文摘 | Chung S Sperling M Biton V | 2007 | Epilepsia2007，48，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员